Prevalence of potential drug-drug interactions and associated factors among elderly patients in Ethiopia: a systematic review and meta-analysis (vol 9, 46, 2024)

被引：0

作者：

Alemayehu, Tekletsadik Tekleslassie ^{[1
]}

Wassie, Yilkal Abebaw ^{[5
]}

Bekalu, Abaynesh Fentahun ^{[2
]}

Tegegne, Addisu Afrassa ^{[4
]}

Ayenew, Wondim ^{[1
]}

Tadesse, Gebresilassie ^{[7
]}

Getachew, Demis ^{[3
]}

Yazie, Abebaw Setegn ^{[9
]}

Teketelew, Bisrat Birke ^{[6
]}

Mekete, Mekonnen Derese ^{[1
,11
]}

Fentahun, Setegn ^{[7
]}

Abebe, Tesfaye Birhanu ^{[8
]}

Minwagaw, Tefera ^{[1
,10
]}

Geremew, Gebremariam Wulie ^{[2
]}

机构：

[1] Univ Gondar, Coll Med & Hlth Sci, Sch Pharm, Dept Social & Adm Pharm, Gondar, Ethiopia

[2] Univ Gondar, Coll Med & Hlth Sci, Sch Pharm, Dept Clin Pharm, Gondar, Ethiopia

[3] Univ Gondar, Coll Med & Hlth Sci, Sch Pharm, Dept Pharmacol, Gondar, Ethiopia

[4] Univ Gondar, Coll Med & Hlth Sci, Sch Pharm, Dept Pharmaceut Chem, Gondar, Ethiopia

[5] Univ Gondar, Coll Med & Hlth Sci, Sch Nursing, Dept Med Nursing, Gondar, Ethiopia

[6] Univ Gondar, Coll Med & Hlth Sci, Sch Biomed & Lab Sci, Dept Hematol & Immunohematol, Gondar, Ethiopia

[7] Univ Gondar, Coll Med & Hlth Sci, Sch Med, Dept Psychiat, Gondar, Ethiopia

[8] Univ Gondar, Coll Med & Hlth Sci, Dept Internal Med, Sch Med, Gondar, Ethiopia

[9] Univ Gondar, Coll Med & Hlth Sci, Dept Med Parasitol, Sch Biomed & Lab Sci, Gondar, Ethiopia

[10] Bahir Dar Univ, Dept Pharm, Bahir Dar, Ethiopia

[11] Debremarkos Univ, Dept Pharm, Debremarkos, Ethiopia

来源：

GLOBAL HEALTH RESEARCH AND POLICY | 2024年 / 9卷 / 01期

关键词：

Associated factors; Elderly; Ethiopia; Potential drug‒drug interaction; Prevalence;

D O I：

10.1186/s41256-024-00402-w

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

BackgroundThe occurrence of potential drug-drug interactions (pDDIs) is a serious global issue that affects all age groups, with the elderly population being the most vulnerable. This is due to their relatively high rates of comorbidity and polypharmacy, as well as physiological changes that can increase the potential for DDIs and the likelihood of adverse drug reactions. The aim of this study was to estimate the prevalence of pDDIs and associated factors among elderly patients in Ethiopia.MethodsA comprehensive literature search using the preferred reporting items for systematic review and meta-analysis statement was conducted on HINARI, Science Direct, Embase, PubMed/MEDLINE, Google Scholar, and Research Gate. Data were extracted via a Microsoft Excel spreadsheet and analyzed via STATA version 11.0. Egger regression tests and funnel plot analysis were used to check publication bias, and the I2 statistic was used to evaluate statistical heterogeneity. Sensitivity and subgroup analyses were also conducted to identify potential causes of heterogeneity.ResultsSeven articles were analyzed, and a total of 1897 pDDIs were identified in 970 patients, resulting in an average of 1.97 DDIs per patient. The number of DDIs per patient ranged from 0.18 to 5.86. The overall prevalence of pDDIs among elderly patients was 50.69% (95% CI 18.77-82.63%). However, the prevalence of pDDIs ranged widely from 2.80 to 90.1%. When the severity of the interactions was considered, the prevalence of potential DDIs was found to be 28.74%, 70.68%, and 34.20% for major, moderate, and minor pDDIs, respectively. Polypharmacy and long hospital stays were identified as factors associated with pDDIs among elderly patients in Ethiopia.ConclusionsThe overall prevalence of pDDIs among elderly patients was high, with a wide range of prevalence rates. Moderate-severity interactions were the most prevalent. Polypharmacy and long hospital stays were identified as factors associated with pDDIs among elderly patients. The study suggests that DDIs identification database itself could have modified the DDIs prevalence rate. As a result, a single DDIs identification database needs to be authorized; otherwise, clinical knowledge should be taken into account when interpreting the information obtained.

引用

页数：1